Bariatric Surgery versus Conventional Medical Therapy for Type 2 Diabetes
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Roux-en-Y gastric bypass and biliopancreatic diversion can markedly ameliorate diabetes in morbidly obese patients, often resulting in disease remission. Prospective, randomized trials comparing these procedures with medical therapy for the treatment of diabetes are needed. METHODS: In this single-center, nonblinded, randomized, controlled trial, 60 patients between the ages of 30 and 60 years with a body-mass index (BMI, the weight in kilograms divided by the square of the height in meters) of 35 or more, a history of at least 5 years of diabetes, and a glycated hemoglobin level of 7.0% or more were randomly assigned to receive conventional medical therapy or undergo either gastric bypass or biliopancreatic diversion. The primary end point was the rate of diabetes remission at 2 years (defined as a fasting glucose level of <100 mg per deciliter [5.6 mmol per liter] and a glycated hemoglobin level of <6.5% in the absence of pharmacologic therapy). RESULTS: At 2 years, diabetes remission had occurred in no patients in the medical-therapy group versus 75% in the gastric-bypass group and 95% in the biliopancreatic-diversion group (P<0.001 for both comparisons). Age, sex, baseline BMI, duration of diabetes, and weight changes were not significant predictors of diabetes remission at 2 years or of improvement in glycemia at 1 and 3 months. At 2 years, the average baseline glycated hemoglobin level (8.65±1.45%) had decreased in all groups, but patients in the two surgical groups had the greatest degree of improvement (average glycated hemoglobin levels, 7.69±0.57% in the medical-therapy group, 6.35±1.42% in the gastric-bypass group, and 4.95±0.49% in the biliopancreatic-diversion group). CONCLUSIONS: In severely obese patients with type 2 diabetes, bariatric surgery resulted in better glucose control than did medical therapy. Preoperative BMI and weight loss did not predict the improvement in hyperglycemia after these procedures. (Funded by Catholic University of Rome; ClinicalTrials.gov number, NCT00888836.).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A total of 8 articles were used across more than 1 component.141,142,144,148,156,159,168,169”
In the citing paper
“The complication evidence base included those studies from the efficacy and predictors searches that included complication data,141,156 as well as those studies that met the expanded search criteria.139,143,145,146,152,153,160,170,171”
In the citing paper
“A total of 10 studies (12 articles) met the inclusion criteria, were rated as good or fair quality, and are included in the summary table.141,142,144,148,151,155,156,159,161,168,169,172”
In the citing paper
“Fifteen RCTs were identified comparing weight loss after bariatric surgery or medical therapy (5 reporting on RYGB, 3 on LAGB and the rest on mixed patient populations undergoing sleeve gastrectomy, BPD/DS, sleeve gastrectomy and/or banding) [21–35].”
In the citing paper
“EWL was similar (WMD 14%, 95% CI − 12.21 to 42.15, very low certainty), whereas long-term morbidity (OR 3.38, 95% CI 1.14 to 10.05, low certainty) and diabetes remission (OR 8.06, 95% CI 1.35 to 48.14) were in favor of RYGB (Supplementary Table S21).”
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Effects of Bariatric Surgery on Mortality in Swedish Obese Subjects
Sjöström, L., Narbro, K., Sjöström, C. D., Karason, K., Larsson, B., Wedel, H., Lystig, T., Sullivan, M., Bouchard, C., Carlsson, B., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066254 · Cited by 4,668
Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery
Sjöström, L., Lindroos, A.-K., Peltonen, M., Torgerson, J., Bouchard, C., Carlsson, B., Dahlgren, S., Larsson, B., Narbro, K., Sjöström, C. D., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035622 · Cited by 4,457
Weight and Type 2 Diabetes after Bariatric Surgery: Systematic Review and Meta-analysis
Buchwald, H., Estok, R., Fahrbach, K., Banel, D., Jensen, M. D., Pories, W. J., Bantle, J. P., & Sledge, I. (2009) · The American Journal of Medicine · doi:10.1016/j.amjmed.2008.09.041 · Cited by 2,551
Bariatric Surgery and Long-term Cardiovascular Events
Sjöström, L., Peltonen, M., Jacobson, P., Sjöström, C. D., Karason, K., Wedel, H., Ahlin, S., Anveden, Å., Bengtsson, C., Bergmark, G., et al. (2012) · JAMA · doi:10.1001/jama.2011.1914 · Cited by 1,656
Meta-Analysis: Surgical Treatment of Obesity
Maggard, M. A., Shugarman, L. R., Suttorp, M., Maglione, M., Sugerman, H. J., Livingston, E. H., Nguyen, N. T., Li, Z., Mojica, W. A., Hilton, L., et al. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-7-200504050-00013 · Cited by 1,567
Dixon, J. B., O’Brien, P. E., Playfair, J., Chapman, L., Schachter, L. M., Skinner, S., Proietto, J., Bailey, M., & Anderson, M. (2008) · JAMA · doi:10.1001/jama.299.3.316 · Cited by 1,434
Global healthcare expenditure on diabetes for 2010 and 2030
Zhang, P., Zhang, X., Brown, J., Vistisen, D., Sicree, R., Shaw, J., & Nichols, G. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2010.01.026 · Cited by 1,145
How do we define cure of diabetes?
Buse, J. B., Caprio, S., Cefalu, W. T., Ceriello, A., Del Prato, S., Inzucchi, S. E., McLaughlin, S., Phillips, G. L., Robertson, R. P., Rubino, F., et al. (2009) · Diabetes Care · doi:10.2337/dc09-9036 · Cited by 1,003
Self-citationRubino, F., Forgione, A., Cummings, D. E., Vix, M., Gnuli, D., Mingrone, G., Castagneto, M., & Marescaux, J. (2006) · Annals of Surgery · doi:10.1097/01.sla.0000224726.61448.1b · Cited by 928
Self-citationLaferrère, B., Teixeira, J., McGinty, J., Tran, H., Egger, J. R., Colarusso, A., Kovack, B., Bawa, B., Koshy, N., Lee, H., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2851 · Cited by 682
Cited by
Items 301–400 of 1,003
Burrin, D. G., Stoll, B., & Moore, D. D. (2013) · Journal of Animal Science · doi:10.2527/jas.2013-6331 · Cited by 68
Schauer, D. P., Arterburn, D. E., Livingston, E. H., Coleman, K. J., Sidney, S., Fisher, D. P., O’Connor, P. J., Fischer, D., & Eckman, M. H. (2015) · Annals of Surgery · doi:10.1097/sla.0000000000000907 · Cited by 67
Managing obesity in adults in primary care
Plourde, G., & Prud’homme, D. (2012) · Canadian Medical Association Journal · doi:10.1503/cmaj.111640 · Cited by 76
Malin, S. K., Bena, J., Abood, B., Pothier, C. E., Bhatt, D. L., Nissen, S. E., Brethauer, S. A., Schauer, P. R., Kirwan, J. P., & Kashyap, S. R. (2014) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12376 · Cited by 62
Chondronikola, M., Harris, L. L. S., & Klein, S. (2016) · Journal of Internal Medicine · doi:10.1111/joim.12527 · Cited by 61
Interventions to Preserve Beta-Cell Function in the Management and Prevention of Type 2 Diabetes
Page, K. A., & Reisman, T. (2013) · Current Diabetes Reports · doi:10.1007/s11892-013-0363-2 · Cited by 64
Obesity diabetes and the role of bile acids in metabolism
TOMKIN, G. H., & Owens, D. (2016) · Journal of Translational Internal Medicine · doi:10.1515/jtim-2016-0018 · Cited by 68
Optimisation of follow-up after metabolic surgery
Mingrone, G., Bornstein, S., & Le Roux, C. W. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30434-5 · Cited by 58
Self-citationCould the improvement of obesity-related co-morbidities depend on modified gut hormones secretion?
Finelli, C. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i44.16649 · Cited by 58
Welbourn, R., Hopkins, J., Dixon, J. B., Finer, N., Hughes, C., Viner, R., Wass, J., & on behalf of the Guidance Development Group (2018) · Obesity Reviews · doi:10.1111/obr.12601 · Cited by 58
Bariatric Surgery as a Long-Term Treatment for Type 2 Diabetes/Metabolic Syndrome
Hanipah, Z. N., & Schauer, P. R. (2020) · Annual Review of Medicine · doi:10.1146/annurev-med-053117-123246 · Cited by 58
Fiorillo, C., Quero, G., Vix, M., Guerriero, L., Pizzicannella, M., Lapergola, A., D’Urso, A., Swanström, L. L., Mutter, D., Dallemagne, B., et al. (2020) · Obesity Surgery · doi:10.1007/s11695-020-04419-1 · Cited by 64
“Bariatric surgery nowadays is the most effective therapy for obesity [9] leading to good results in terms of long-term weight loss and an improvement obesity-related comorbidities [10, 11].”
BackgroundHolman, N., Wild, S. H., Khunti, K., Knighton, P., O’Keefe, J., Bakhai, C., Young, B., Sattar, N., Valabhji, J., & Gregg, E. W. (2022) · Diabetes Care · doi:10.2337/dc21-2136 · Cited by 55
Salinari, S., le Roux, C. W., BERTUZZI, A., Rubino, F., & Mingrone, G. (2013) · Diabetes · doi:10.2337/db13-0856 · Cited by 61
Self-citationZheng, H., Zhao, Z., Berthoud, H., & Ye, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0052922 · Cited by 61
Kaplan, U., Penner, S., Farrokhyar, F., Andruszkiewicz, N., Breau, R., Gmora, S. B., Hong, D., & Anvari, M. (2018) · Obesity Surgery · doi:10.1007/s11695-018-3160-9 · Cited by 57
Safety and Efficacy of Bariatric and Metabolic Surgery
Ghiassi, S., & Morton, J. M. (2020) · Current Obesity Reports · doi:10.1007/s13679-020-00377-y · Cited by 61
Pharmacotherapies for post-bariatric weight regain: real-world comparative outcomes
Gazda, C. L., Clark, J. D., Lingvay, I., & Almandoz, J. P. (2021) · Obesity · doi:10.1002/oby.23146 · Cited by 56
Type 2 diabetes and cardiovascular disease: what next?
Joseph, J. J., & Golden, S. H. (2014) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0000000000000044 · Cited by 57
Malin, S. K., Samat, A., Wolski, K., Abood, B., Pothier, C. E., Bhatt, D. L., Nissen, S. E., Brethauer, S. A., Schauer, P. R., Kirwan, J. P., et al. (2013) · International Journal of Obesity · doi:10.1038/ijo.2013.196 · Cited by 62
Duca, F. A., Bauer, P. V., Hamr, S. C., & Lam, T. K. T. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.07.003 · Cited by 64
The Surgical Management of Obesity
Neylan, C. J., Kannan, U., Dempsey, D. T., Williams, N. N., & Dumon, K. R. (2016) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2016.07.006 · Cited by 62
Metabolic Surgery for Hypertension in Patients With Obesity
Pareek, M., Bhatt, D. L., Schiavon, C. A., & Schauer, P. R. (2019) · Circulation Research · doi:10.1161/circresaha.118.313320 · Cited by 64
Khan, Z. H., Khan, M. A., Hajifathalian, K., Shah, S. L., Abdul, M., Saumoy, M., Aronne, L. J., Lee‐Smith, W., & Sharaiha, R. Z. (2019) · Obesity Surgery · doi:10.1007/s11695-019-03865-w · Cited by 59
Enochs, P., Bull, J., Surve, A., Cottam, D. R., Bovard, S., Bruce, J., Tyner, M., Pilati, D., & Cottam, S. (2019) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2019.10.008 · Cited by 59
“Mingrone et al. [49] showed that the more the small intestine is bypassed, the higher the T2D resolution rates.”
BackgroundSteven, S., Carey, P. E., Small, P. K., & Taylor, R. (2015) · Diabetic Medicine · doi:10.1111/dme.12567 · Cited by 55
Bariatric surgery: a best practice article
Neff, K. J. H., & le Roux, C. W. (2013) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2012-200798 · Cited by 55
Doumouras, A. G., Lee, Y., Paterson, J. M., Gerstein, H. C., Shah, B. R., Sivapathasundaram, B., Tarride, J.-E., Anvari, M., & Hong, D. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.6820 · Cited by 55
Kanbour, S., Ageeb, R. A., Malik, R. A., & Abu-Raddad, L. J. (2025) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(24)00346-2 · Cited by 75
Coleman, K. J., & Brookey, J. (2014) · Obesity Surgery · doi:10.1007/s11695-014-1268-0 · Cited by 60
Kim, J. J., Eisenberg, D., Azagury, D. E., Rogers, A. M., & Campos, G. M. (2015) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2015.11.021 · Cited by 67
Bariatric surgery and obesity: influence on the incretins
Laferrère, B. (2016) · International Journal of Obesity Supplements · doi:10.1038/ijosup.2016.8 · Cited by 57
Plourde, C., Grenier–Larouche, T., Caron‐Dorval, D., Biron, S., Marceau, S., Lebel, S., Biertho, L. D., Tchernof, A., Richard, D., & Carpentier, A. C. (2014) · Obesity · doi:10.1002/oby.20771 · Cited by 55
Salinari, S., Debard, C., Bertuzzi, A., Durand, C., Zimmet, P., Vidal, H., & Mingrone, G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056258 · Cited by 54
“Two recent studies demonstrated that bariatric surgery induced remission of T2D and significant improvement in metabolic control of the diabetes over and above medical therapy [5,25].”
BackgroundSelf-citationAmor, A. J., Jiménez, A., Moize, V. L., Ibarzábal, A., Flores, L., Lacy, A. M., & Vidal, J. (2013) · Surgical Endoscopy · doi:10.1007/s00464-012-2708-3 · Cited by 59
CASELLINI, C. M., Parson, H. K., Hodges, K., Edwards, J., Lieb, D. C., Wohlgemuth, S. D., & Vinik, A. I. (2016) · PLoS ONE · doi:10.1371/journal.pone.0154211 · Cited by 58
Li, K., Zhang, P., Di, J., Han, X., Hao-yong, Y., Yuqian, B., & Hongwei, Z. (2014) · Obesity Surgery · doi:10.1007/s11695-014-1465-x · Cited by 59
“Currently, the growing consensus for treatment of ED favors bariatric surgery [11–13], which achieves substantial weight loss, significantly improves metabolic syndrome, and relieves type 2 diabetes [14, 15].”
BackgroundWang, M. C., Guo, X. H., Zhang, Y., Zhang, Y. L., Zhang, H. H., & Zhang, Y. C. (2015) · The American Surgeon™ · doi:10.1177/000313481508100229 · Cited by 53
Diabetes remission after bariatric surgery
Chumakova-Orin, M., Vanetta, C., Moris, D., & Guerron, A. D. (2021) · World Journal of Diabetes · doi:10.4239/wjd.v12.i7.1093 · Cited by 69
TFOS Lifestyle: Impact of nutrition on the ocular surface
Markoulli, M. P., Ahmad, S., Arcot, J., Arita, R., Benitez-del-Castillo, J., Caffery, B. E., Downie, L. E., Edwards, K. P., Flanagan, J., Labétoulle, M., et al. (2023) · The Ocular Surface · doi:10.1016/j.jtos.2023.04.003 · Cited by 75
Physiological Mechanisms behind Roux-en-Y Gastric Bypass Surgery
Lutz, T. A., & Bueter, M. (2014) · Digestive Surgery · doi:10.1159/000354319 · Cited by 60
Basso, N., Soricelli, E., Castagneto-Gissey, L., Casella, G., Albanese, D., Fava, F., Donati, C., Tuohy, K., Angelini, G., La Neve, F., et al. (2016) · Diabetes · doi:10.2337/db16-0039 · Cited by 53
Self-citationThe impact of bariatric surgery on inflammation: quenching the fire of obesity?
Hafida, S., Mirshahi, T., & Nikolajczyk, B. S. (2016) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000277 · Cited by 58
Piloting a Remission Strategy in Type 2 Diabetes: Results of a Randomized Controlled Trial
McInnes, N., Smith, A., Otto, R., Vandermey, J., Punthakee, Z., Sherifali, D., Balasubramanian, K., Hall, S., & Gerstein, H. C. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-3373 · Cited by 53
Surgery in Patients with Super Obesity: Medium‐Term Follow‐Up Outcomes at a High‐Volume Center
Bhandari, M., de León‐Ballesteros, G. P., Kosta, S., Bhandari, M., Humes, T., Mathur, W., & Fobi, M. A. L. (2019) · Obesity · doi:10.1002/oby.22593 · Cited by 54
“Obesity predisposes to different potentially life-threatening conditions, including but not limited to type 2 diabetes mellitus (T2DM), hypertension, cardiovascular disease, hypercoagulability, deep vein thrombosis, pulmonary embolism, and increased risks for wound infection (3,4).”
BackgroundGerber, P., Anderin, C., Gustafsson, U. O., & Thorell, A. (2015) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2015.08.519 · Cited by 55
Which criteria should be used to define type 2 diabetes remission after bariatric surgery?
Ramos-Levi, A. M., Cabrerizo, L., Matía, P., Sánchez-Pernaute, A., Torres, A. J., & Rubio, M. A. (2013) · BMC Surgery · doi:10.1186/1471-2482-13-8 · Cited by 52
The physiology of altered eating behaviour after Roux‐en‐Y gastric bypass
le Roux, C. W., & Bueter, M. (2014) · Experimental Physiology · doi:10.1113/expphysiol.2014.078378 · Cited by 62
Perrone, F., Bianciardi, E., Ippoliti, S., Nardella, J., Fabi, F., & Gentileschi, P. (2017) · Updates in Surgery · doi:10.1007/s13304-017-0426-z · Cited by 58
Lecube, A., Monereo, S., Rubio, M. Á., de Icaya, P. M., Martí, A., Salvador, J., Masmiquel, L., Goday, A., Bellido, D., Lurbe, E., et al. (2017) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endien.2017.03.007 · Cited by 76
Sears, B., & Ricordi, C. (2012) · PubMed · Cited by 75
Mainous, A. G., Johnson, S. P., Saxena, S. K., & Wright, R. U. (2013) · The American Journal of Gastroenterology · doi:10.1038/ajg.2012.365 · Cited by 54
Korda, R., Joshy, G., Jorm, L. R., Butler, J. R., & Banks, E. (2012) · The Medical Journal of Australia · doi:10.5694/mja12.11035 · Cited by 55
Incretin-based therapies: where will we be 50 years from now?
Meier, J. J., & Nauck, M. A. (2015) · Diabetologia · doi:10.1007/s00125-015-3608-6 · Cited by 58
Chemosensory signalling pathways involved in sensing of amino acids by the ghrelin cell
Vancleef, L., den Broeck, T. V., Thijs, T., Steensels, S., Briand, L. V., Tack, J. F., & Depoortere, I. (2015) · Scientific Reports · doi:10.1038/srep15725 · Cited by 64
Cottam, A., Cottam, D. R., Zaveri, H., Cottam, S., Surve, A., Medlin, W., & Richards, C. (2018) · Obesity Surgery · doi:10.1007/s11695-018-3309-6 · Cited by 55
Beyond gut microbiota: understanding obesity and type 2 diabetes
Lau, E., Carvalho, D. M., Pina‐Vaz, C., Barbosa, J.-A., & Freitas, P. (2015) · HORMONES · doi:10.14310/horm.2002.1571 · Cited by 65
Marginal ulcer continues to be a major source of morbidity over time following gastric bypass
Pyke, O. J., Yang, J., Cohn, T. D., Yin, D., Docimo, S., Talamini, M. A., Bates, A. T., Pryor, A. D., & Spaniolas, K. (2018) · Surgical Endoscopy · doi:10.1007/s00464-018-06618-5 · Cited by 51
Schiavon, C. A., Ikeoka, D., Santucci, E. V., Santos, R. N., Damiani, L. P., Bueno, P. R. T., de Oliveira, J. D., Torreglosa, C. R., Bersch-Ferreira, Â. C., Miranda, T. A., et al. (2019) · Hypertension · doi:10.1161/hypertensionaha.118.12290 · Cited by 53
Diabetes after Bariatric Surgery
Shah, A., & Laferrère, B. (2017) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2016.12.009 · Cited by 50
Vagal Nerve Stimulation for Glycemic Control in a Rodent Model of Type 2 Diabetes
Yin, J., Ji, F. Y., Gharibani, P. M., & Chen, J. D. Z. (2019) · Obesity Surgery · doi:10.1007/s11695-019-03901-9 · Cited by 59
“Metabolic surgery has been considered for treating T2DM as well [8, 9].”
Pathogenesis, diagnosis and treatment of non-alcoholic fatty liver disease
Domínguez, V. M., González-Casas, R., Jiménez-Ridruejo, J. M., García-Buey, L., & Moreno‐Otero, R. (2013) · Revista Española de Enfermedades Digestivas · doi:10.4321/s1130-01082013000700006 · Cited by 79
Brown Adipose Tissue: Research Milestones of a Potential Player in Human Energy Balance and Obesity
Zafrir, B. (2013) · Hormone and Metabolic Research · doi:10.1055/s-0033-1348264 · Cited by 61
Friedrich, A. E., Damms-Machado, A., Meile, T., Scheuing, N., Stingel, K., Basrai, M., Küper, M. A., Kramer, K. M., Königsrainer, A., & Bischoff, S. C. (2013) · Obesity Surgery · doi:10.1007/s11695-013-1036-6 · Cited by 57
Schauer, P. R., Hanipah, Z. N., & Rubino, F. (2017) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.84.s1.06 · Cited by 56
Self-citationComparison of Bariatric Surgical Procedures for Diabetes Remission: Efficacy and Mechanisms
Vetter, M. L., Ritter, S., Wadden, T. A., & Sarwer, D. B. (2012) · Diabetes Spectrum · doi:10.2337/diaspect.25.4.200 · Cited by 54
Prediction of Diabetes Remission in Morbidly Obese Patients After Roux-en-Y Gastric Bypass
Park, J. Y., & Kim, Y. J. (2015) · Obesity Surgery · doi:10.1007/s11695-015-1823-3 · Cited by 56
Role of proximal gut exclusion from food on glucose homeostasis in patients with Type 2 diabetes
COHEN, R. V., le Roux, C. W., Papamargaritis, D., Salles, J. E. N., Petry, T. B. Z., Correa, J. L., Pournaras, D. J., Neto, M. G., Martins, B. D. C., Sakai, P., et al. (2013) · Diabetic Medicine · doi:10.1111/dme.12268 · Cited by 52
Chiappetta, S., Stier, C. K., Squillante, S., Theodoridou, S., & Weiner, R. A. (2016) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2016.02.042 · Cited by 52
Improved glucose metabolism after gastric bypass: evolution of the paradigm
Pournaras, D. J., Nygren, J., Hagström-Toft, E., Arner, P., le Roux, C. W., & Thorell, A. (2016) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2016.03.020 · Cited by 48
Bariatric surgery and diabetes remission: Who would have thought it?
Singh, A., Singh, R., & Kota, S. (2015) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.163113 · Cited by 48
Bile Acids, FXR, and Metabolic Effects of Bariatric Surgery
Noel, O. F., Still, C. D., Argyropoulos, G. A., Edwards, M. A., & Gerhard, G. S. (2016) · Journal of Obesity · doi:10.1155/2016/4390254 · Cited by 53
Salehi, M., Woods, S. C., & D'Alessio, D. A. (2015) · Obesity · doi:10.1002/oby.21186 · Cited by 48
Nguyen, K. T., & Körner, J. (2014) · Current Diabetes Reports · doi:10.1007/s11892-014-0481-5 · Cited by 51
Ardestani, A., Rhoads, D., & Tavakkoli, A. (2015) · Diabetes Care · doi:10.2337/dc14-1751 · Cited by 47
Jiménez, A., Ceriello, A., Casamitjana, R., Flores, L., Viaplana-Masclans, J., & Vidal, J. (2014) · Annals of Surgery · doi:10.1097/sla.0000000000000586 · Cited by 51
Tamboli, R. A., Breitman, I., Marks‐Shulman, P. A., Jabbour, K., Melvin, W., Williams, B., Clements, R. H., Feurer, I. D., & Abumrad, N. N. (2014) · Obesity · doi:10.1002/oby.20776 · Cited by 48
The Use of Rat and Mouse Models in Bariatric Surgery Experiments
Lutz, T. A., & Bueter, M. (2016) · Frontiers in Nutrition · doi:10.3389/fnut.2016.00025 · Cited by 57
Surgery or Medical Therapy for Obese Patients with Type 2 Diabetes?
Zimmet, P., & Alberti, K. G. M. M. (2012) · New England Journal of Medicine · doi:10.1056/nejme1202443 · Cited by 48
Ding, L., Zhang, E., Yang, Q., Jin, L., Sousa, K. M., Dong, B., Wang, Y., Tu, J., Ma, X., Tian, J., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2019388118 · Cited by 50
Michaud, A., Marchand, G. B., Nadeau, M., Lebel, S., Hould, F., Marceau, S., Lescelleur, O., Biron, S., Tchernof, A., & Biertho, L. D. (2015) · Obesity Surgery · doi:10.1007/s11695-015-1772-x · Cited by 48
Patel, R. T., Shukla, A. P., Ahn, S. M., Moreira, M., & Rubino, F. (2013) · Obesity · doi:10.1002/oby.20441 · Cited by 51
Self-citationWhat is the impact on the healthcare system if access to bariatric surgery is delayed?
COHEN, R. V., Luque, A., Junqueira, S. M., Ribeiro, R. A., & le Roux, C. W. (2017) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2017.03.025 · Cited by 55
Altered glucose metabolism after bariatric surgery: What's GLP-1 got to do with it?
Smith, E. P., Polanco, G., Yaqub, A., & Salehi, M. (2017) · Metabolism · doi:10.1016/j.metabol.2017.10.014 · Cited by 54
Impact of Different Criteria on Type 2 Diabetes Remission Rate After Bariatric Surgery
On Behalf of the Obemar Group, Mas-Lorenzo, A., Benaiges, D., Roux, J. A. F., Pedro-Botet, J., Ramón, J. M., Parri, A., Villatoro, M., Chillarón, J. J., Pera, M., et al. (2014) · Obesity Surgery · doi:10.1007/s11695-014-1282-2 · Cited by 51
Doğan, K., Betzel, B., Homan, J., Aarts, E. O., Ploeger, N., de Boer, H., Aufenacker, T. J., van Laarhoven, C. J. H. M., Janssen, I. M. C., & Berends, F. J. (2014) · Obesity Surgery · doi:10.1007/s11695-014-1310-2 · Cited by 52
Martin, W. P., White, J. P., López-Hernández, F. J., Docherty, N. G., & le Roux, C. W. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00289 · Cited by 53
Ribeiro-Parenti, L., Jarry, A.-C., Cavin, J.-B., Willemetz, A., Le Beyec, J., Sannier, A., Benadda, S., Pelletier, A.-L., Hourseau, M., Léger, T., et al. (2021) · Nature Communications · doi:10.1038/s41467-020-20301-1 · Cited by 46
Ramos-Levi, A. M., Matía‐Martín, P., Cabrerizo, L., Barabash, A., Sánchez-Pernaute, A., Calle‐Pascual, A. L., Torres, A. J., & Rubio, M. Á. (2014) · Journal of Diabetes · doi:10.1111/1753-0407.12127 · Cited by 49
Bhasker, A. G., Remedios, C., Batra, P. J., Sood, A., Shaikh, S. S., & Lakdawala, M. A. (2014) · Obesity Surgery · doi:10.1007/s11695-014-1501-x · Cited by 46
“In the last few years, three randomized controlled trials have yielded level 1 evidence and proved that control of T2DM in obese diabetics is far superior with patients who have undergone LRYGB as compared to those receiving medical management alone [13–15].”
ResultShukla, A. P., Buniak, W. I., & Aronne, L. J. (2015) · Journal of Cardiopulmonary Rehabilitation and Prevention · doi:10.1097/hcr.0000000000000112 · Cited by 61
Neff, K., Baud, G., Raverdy, V., Caiazzo, R. J., Verkindt, H., Noël, C., le Roux, C. W., & Pattou, F. N. (2016) · Obesity Surgery · doi:10.1007/s11695-016-2333-7 · Cited by 48
Neuroendocrine adaptations to bariatric surgery
Dixon, J. B., Lambert, É., & Lambert, G. W. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.05.033 · Cited by 47
Mottalib, A., Sakr, M., Shehabeldin, M., & Hamdy, O. (2015) · Journal of Diabetes Research · doi:10.1155/2015/468704 · Cited by 44
“Bariatric surgery has been reported to improve type 2 diabetes and was shown to be superior to medical intervention [2, 9].”
BackgroundInfluentialJanssen, I. M. C., Homan, J., Schijns, W., Betzel, B., Aarts, E. O., Berends, F. J., & de Boer, H. (2015) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2015.02.021 · Cited by 53
Insulin Status and Vascular Responses to Weight Loss in Obesity
Bigornia, S., Farb, M. G., Tiwari, S., Karki, S., Hamburg, N. M., Vita, J. A., Hess, D. T., LaValley, M. P., Apovian, C. M., & Gokce, N. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.07.078 · Cited by 47
Incretins or Anti-Incretins? A New Model for the “Entero-Pancreatic Axis”
Kamvissi, V., Salerno, A., Bornstein, S. R., Mingrone, G., & Rubino, F. (2014) · Hormone and Metabolic Research · doi:10.1055/s-0034-1394374 · Cited by 55
Self-citationWharton, S., Sharma, A. M., & Lau, D. C. W. (2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.01.025 · Cited by 54
Recent advances in metabolic and bariatric surgery
Albaugh, V. L., Flynn, C. R., Tamboli, R. A., & Abumrad, N. N. (2016) · F1000Research · doi:10.12688/f1000research.7240.1 · Cited by 56
Resolution of Comorbidities and Impact on Longevity Following Bariatric and Metabolic Surgery
Fouse, T., & Brethauer, S. A. (2016) · Surgical Clinics of North America · doi:10.1016/j.suc.2016.03.007 · Cited by 55
Metadata
- Authors
- Mingrone, G., Panunzi, S., De Gaetano, A., Guidone, C., Iaconelli, A., Leccesi, L., Nanni, G., Pomp, A., Castagneto, M., Ghirlanda, G., & Rubino, F.
- Affiliations
- Università Cattolica del Sacro Cuore (IT)
- NewYork–Presbyterian Hospital (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2012-04-26
- Volume
- 366
- Issue
- 17
- Pages
- 1577-1585
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2144631980
- Semantic Scholar
- a28bc983875a6b8fd043b1d228160f79128d4ce9
- Cited by
- 1,791
- References
- 25
- Citations by year
- 2026: 56 · 2025: 60 · 2024: 57 · 2023: 66 · 2022: 90 · 2021: 81 · 2020: 111 · 2019: 99 · 2018: 117 · 2017: 129 · 2016: 156 · 2015: 231 · 2014: 201 · 2013: 215 · 2012: 115
- FWCI
- 248.19
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Research Portal (King's College London) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
- Health Sciences › Medicine › Surgery › Minimally Invasive Surgical Techniques
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- bariatric surgery, type 2 diabetes, Roux-en-Y gastric bypass, biliopancreatic diversion, diabetes remission, morbid obesity, HbA1c, glycemic control, medical therapy, predictors of remission
- MeSH terms
- Adult, Analysis of Variance, Diabetes Mellitus, Type 2, Female, Follow-Up Studies, Glycated Hemoglobin, Humans, Hypoglycemic Agents, Insulin, Lipids, Male, Middle Aged, Obesity, Morbid, Remission Induction, Gastric Bypass, Weight Loss, Biliopancreatic Diversion, Body Mass Index
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.